Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > Gross Margin

Apellis Pharmaceuticals Inc Gross Margin Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly Gross Margin from 2019 to 2019. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
Other Margins & Efficiency Metrics:
  • Apellis Pharmaceuticals Inc Return on Capital % for the quarter ending September 09, 2018 was -37.36 a -28.40% increase of 10.61 year over year
  • Apellis Pharmaceuticals Inc Return on Equity % for the quarter ending September 09, 2018 was -67.63 a -34.01% increase of 23.00 year over year
View Chart On Koyfin